₹4,225
▲ +2.96 +0.07%
17 Jul 2026
NSE Listed
Bayer Cropscience Ltd. (BAYERCROP)
20-day avg volume: 40K shares
- Healthy return on equity of 23.2%.
- Pays a dividend yield of 142.0%.
- Company is almost debt-free.
- Revenue fell 12% YoY.
- Stock trades at a high P/E of 117.
| Metric | Dec 2002 | Dec 2003 | Dec 2004 | Dec 2005 | Dec 2006 |
|---|---|---|---|---|---|
| Revenue | ₹108 Cr | ₹447 Cr | ₹214 Cr | ₹223 Cr | ₹242 Cr |
| EBITDA | ₹-3 Cr | ₹29 Cr | ₹9 Cr | ₹29 Cr | ₹29 Cr |
| Net Profit | ₹-5 Cr | ₹13 Cr | ₹-3 Cr | ₹8 Cr | ₹17 Cr |
| EPS | — | — | — | — | — |
| Metric | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|
| Revenue | ₹3,220 Cr | ₹3,675 Cr | ₹4,325 Cr | ₹4,789 Cr | ₹5,204 Cr | ₹5,184 Cr | ₹5,593 Cr | ₹5,675 Cr |
| EBITDA | ₹490 Cr | ₹727 Cr | ₹802 Cr | ₹801 Cr | ₹909 Cr | ₹961 Cr | ₹724 Cr | ₹0 Cr |
| Net Profit | ₹337 Cr | ₹475 Cr | ₹493 Cr | ₹645 Cr | ₹758 Cr | ₹741 Cr | ₹568 Cr | ₹689 Cr |
| EPS | 78.46 | 105.58 | 109.72 | 143.58 | 168.71 | 164.77 | 126.38 | — |
| Metric | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|
| Total Assets | ₹3,549 Cr | ₹3,836 Cr | ₹4,239 Cr | ₹4,353 Cr | ₹4,679 Cr | ₹4,597 Cr | ₹5,246 Cr | ₹5,699 Cr |
| Total Liabilities | ₹1,310 Cr | ₹1,263 Cr | ₹1,689 Cr | ₹1,829 Cr | ₹1,967 Cr | ₹1,748 Cr | ₹2,396 Cr | ₹2,734 Cr |
| Equity | ₹2,239 Cr | ₹2,573 Cr | ₹2,550 Cr | ₹2,524 Cr | ₹2,712 Cr | ₹2,849 Cr | ₹2,850 Cr | ₹2,966 Cr |
| Total Debt | — | — | — | — | — | — | — | ₹82 Cr |
| Metric | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|
| Operating | ₹849 Cr | ₹480 Cr | ₹849 Cr | ₹1,084 Cr | ₹424 Cr | ₹1,079 Cr |
| Investing | ₹7 Cr | ₹64 Cr | ₹83 Cr | ₹0 Cr | ₹86 Cr | ₹73 Cr |
| Financing | ₹-556 Cr | ₹-703 Cr | ₹-613 Cr | ₹-656 Cr | ₹-619 Cr | ₹-624 Cr |
| Free Cash Flow | ₹849 Cr | ₹480 Cr | ₹849 Cr | ₹1,084 Cr | ₹424 Cr | ₹1,014 Cr |
Agro Chemicals · Pesticides / Agrochemicals - Multinational
Bayer CropScience Limited engages in the manufacture, sale, and distribution of insecticides, fungicides, herbicides, and various other agrochemical products and hybrid corn seeds in India, Germany, Bangladesh, and internationally. It provides medicines in the therapeutic areas of cardiology, gynecology, diabetes, oncology, and ophthalmology; and computed tomography, X-Ray, and magnetic resonance imaging devices. In addition, the company offers consumer health products that are used as a daily health solution to treat minor illnesses, as well as sells and distributes row crop hybrid seeds. Further, it provides digital farming products comprising FarmRise and other digital applications, as well as tools, including remote sensing, IoT sensors, GPS, drones, artificial intelligence, and data analytics to monitor and manage crop growth, soil health, and weather conditions. The company also exports its products. Bayer CropScience Limited was founded in 1896 and is based in Thane, India.
www.bayer.in ↗As of 2026-03-31
Quarterly — figures in %. Latest 12 quarters.
| Period | Jun 2023 | Sept 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sept 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sept 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Promoters | 71.4% | 71.4% | 71.4% | 71.4% | 71.4% | 71.4% | 71.4% | 71.4% | 71.4% | 71.4% | 71.4% | 71.4% |
| FIIs | 3.2% | 3.3% | 3.5% | 3.6% | 3.6% | 3.3% | 3.4% | 3.5% | 3.6% | 3.8% | 3.8% | 3.9% |
| DIIs | 13% | 13.2% | 12.7% | 12.8% | 12.5% | 12.1% | 11.7% | 11.6% | 11.4% | 11.2% | 11.5% | 11.9% |
| Public | 12.4% | 12.1% | 12.4% | 12.1% | 12.5% | 13.2% | 13.4% | 13.5% | 13.6% | 13.6% | 13.3% | 12.8% |
| Promoter Pledge | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| No. of Shareholders | 48,404 | 45,329 | 46,907 | 45,852 | 46,201 | 51,289 | 54,289 | 54,216 | 55,753 | 58,109 | 58,571 | 55,795 |
| Period | ROE | ROCE | ROA | P/E |
|---|---|---|---|---|
| 202503 | — | — | — | — |
| Name | Category | Stake | Shares |
|---|---|---|---|
| Bayer Vapi Private Limited | Shareholding of Promoter and Promoter Group | 17.9% | 80,39,736 |
| Bayer Investments India Private Limited | Shareholding of Promoter and Promoter Group | 15% | 67,58,082 |
| Bayer Sas | Shareholding of Promoter and Promoter Group | 14.7% | 66,18,105 |
| Bayer Cropscience Ag | Shareholding of Promoter and Promoter Group | 11.9% | 53,54,030 |
| Bayer Ag | Shareholding of Promoter and Promoter Group | 8.4% | 37,88,433 |
| Monsanto Company | Shareholding of Promoter and Promoter Group | 3.4% | 15,44,613 |
| Quant Mutual Fund - Quant Small Cap Fund | Public Shareholding | 2.3% | 10,37,211 |
| Nippon Life India Trustee Ltd-a/c Nippon India Small Cap Fund | Public Shareholding | 2% | 8,86,158 |
| Aditya Birla Sun Life Trustee Private Limited A/c - Aditya Birla Sun Life Large Cap Fund | Public Shareholding | 1.2% | 5,39,931 |
| Bandhan Elss Tax Saver Fund | Public Shareholding | 1.2% | 5,18,778 |
| Holder | Pledged Shares | % of Holding | As of |
|---|---|---|---|
| Bayer Vapi Private Limited | 0 | 0% | 2026-03-31 |
| Bayer Investments India Private Limited | 0 | 0% | 2026-03-31 |
| Bayer Sas | 0 | 0% | 2026-03-31 |
| Bayer Cropscience Ag | 0 | 0% | 2026-03-31 |
| Bayer Ag | 0 | 0% | 2026-03-31 |
| Monsanto Company | 0 | 0% | 2026-03-31 |
| Quant Mutual Fund - Quant Small Cap Fund | 0 | 0% | 2026-03-31 |
| Nippon Life India Trustee Ltd-a/c Nippon India Small Cap Fund | 0 | 0% | 2026-03-31 |
| Aditya Birla Sun Life Trustee Private Limited A/c - Aditya Birla Sun Life Large Cap Fund | 0 | 0% | 2026-03-31 |
| Bandhan Elss Tax Saver Fund | 0 | 0% | 2026-03-31 |
| Bayer Vapi Private Limited | 0 | 0% | 2025-12-31 |
| Bayer Investments India Private Limited | 0 | 0% | 2025-12-31 |
| Name | Designation | Year |
|---|---|---|
| Pankaj Patel | Chairman & Independent Director | 2025 |
| Thomas Hoffmann | Non-Executive & Non-Independent Director | 2025 |
| Simon Wiebusch | Vice Chairman & MD & CEO | 2025 |
| Radhika Rajan | Independent Director | 2025 |
| Jana Marlen Ackermann | Non-Executive & Non-Independent Director | 2025 |
| Mr Sanjiv Rangrass | Independent Director | 2025 |
| Vinit Rajesh Jindal | Whole Time Director & Chief Financial Officer | 2025 |
| Bharati Shetty | Company Sec. & Compli. Officer | 2025 |
| Segment | Revenue | Share |
|---|---|---|
| Agri Care | ₹0 Cr | — |
| Region | Revenue | Share |
|---|---|---|
| India | ₹5,212 Cr | 95.2% |
| Germany | ₹93 Cr | 1.7% |
| Bangladesh | ₹91 Cr | 1.7% |
| Others | ₹78 Cr | 1.4% |
| Year | Face Value | Authorised | Issued | Paid-up |
|---|---|---|---|---|
| 2025 | ₹10 | 66 | 45 | 45 |
| Type | Date | Value | Remark |
|---|---|---|---|
| dividend | 2025-11-14 | ₹90 (900%) | Interim |
| dividend | 2025-08-07 | ₹35 (350%) | Final |
| forthcoming | — | Book Closure | AGM & 600% Final Dividend |
| Year | Subsidiaries | Associates | JV | KMP | Others | Total |
|---|---|---|---|---|---|---|
| 2025 | 0 | 0 | 0 | 17 | 1,293 | 3,955 |
| 2025 | 0 | 0 | 0 | 0 | 20 | 20 |
| 2025 | 0 | 0 | 0 | 17 | 1,026 | 3,594 |
📍 Bayer House Central Avenue, Hiranandani Estate, Thane (West), Maharashtra, 400607
Technical analysis (Premium)
Log in to see RSI, MACD, moving averages, oscillators and pivot levels for this stock.
More stocks
Prices are delayed/indicative; pros & cons are AI generated. Informational only — not investment advice. ← Back to search